TdIF1: a putative oncogene in NSCLC tumor progression.
Zhang Y, Wang Z, Huang Y, Ying M, Wang Y, Xiong J, Liu Q, Cao F, Joshi R, Liu Y, Xu D, Zhang M, Yuan K, Zhou N, Koropatnick J, Min W.
Zhang Y, et al. Among authors: yuan k.
Signal Transduct Target Ther. 2018 Oct 19;3:28. doi: 10.1038/s41392-018-0030-9. eCollection 2018.
Signal Transduct Target Ther. 2018.
PMID: 30345081
Free PMC article.